|Articles|November 8, 2022

OneStudyTeam and Antidote Announce Partnership

OneStudyTeam and Antidote Technologies announced a partnership to provide sites and sponsors with a connected, patient referral management experience to give them control in clinical trial recruitment efforts.

Trending on Applied Clinical Trials Online

OneStudyTeam and Antidote Announce Partnership

Related Content

Real-World Evidence in Transition: CRO Adaptation to the European Health Data Space Framework

Why Coordination Failures Get Blamed on Vendors When the Problem Started Much Earlier

ACT Brief: Sponsor Oversight Capability Gaps, Community-Embedded Trial Partnerships, and Trialblazer Timeline Realism

Two New Partnerships Aim to Expand Patient Access to Clinical Trials Through Community-Based Research

Where Capability Gaps Hide When Scientific Intent Doesn't Translate Into Operations

Trending on Applied Clinical Trials Online

Two New Partnerships Aim to Expand Patient Access to Clinical Trials Through Community-Based Research

ACT Brief: Sponsor Oversight Capability Gaps, Community-Embedded Trial Partnerships, and Trialblazer Timeline Realism

ACT Brief: Product Development Assumptions, Portfolio-Level Recruitment Infrastructure, and Risk-Based Quality Integration

ACT Brief: Portfolio-Level Recruitment Strategy, Structural Change Through Systems Thinking, and Kidney Function Preservation in IgAN

ACT Brief: Sponsor Accountability in Outsourcing, Biomarker Strategy in Precision Oncology, and Novel Sciatica Therapy